Zobrazeno 1 - 10
of 18
pro vyhledávání: '"Yucai Wang"'
Autor:
Allison M. Bock, Jennifer J. Gile, Melissa C. Larson, Kittika Poonsombudlert, Reema K. Tawfiq, Seth Maliske, Matthew J. Maurer, Brian F. Kabat, Jonas Paludo, David J. Inwards, Sabarish Ayyappan, Brian K. Link, Stephen M. Ansell, Thomas M. Habermann, Thomas E. Witzig, Grzegorz S. Nowakowski, James R. Cerhan, Umar Farooq, Yucai Wang
Publikováno v:
Blood Cancer Journal, Vol 13, Iss 1, Pp 1-9 (2023)
Abstract Over the last two decades, the frontline therapy for mantle cell lymphoma (MCL) has evolved. However, the impact of subsequent lines of therapy on survival outcomes has not been well characterized. In this study, we investigated the treatmen
Externí odkaz:
https://doaj.org/article/ab1b048610ec4f4e949d375e8ba8630b
Autor:
William G. Breen, Jason R. Young, Matthew A. Hathcock, Roman O. Kowalchuk, Matthew P. Thorpe, Radhika Bansal, Arushi Khurana, N. Nora Bennani, Jonas Paludo, Jose Villasboas Bisneto, Yucai Wang, Stephen M. Ansell, Jennifer L. Peterson, Patrick B. Johnston, Scott C. Lester, Yi Lin
Publikováno v:
Blood Cancer Journal, Vol 13, Iss 1, Pp 1-5 (2023)
Abstract PET/CT is used to evaluate relapsed/refractory non-Hodgkin lymphoma (NHL) prior to chimeric antigen receptor T-cell (CAR-T) infusion at two time points: pre-leukapheresis (pre-leuk) and pre-lymphodepletion chemotherapy (pre-LD). We hypothesi
Externí odkaz:
https://doaj.org/article/2216cd6058cc41c898d1c89beb34f7cd
Autor:
Paul J. Hampel, Kari G. Rabe, Timothy G. Call, Wei Ding, Jose F. Leis, Asher A. Chanan-Khan, Saad S. Kenderian, Eli Muchtar, Yucai Wang, Sikander Ailawadhi, Amber B. Koehler, Ricardo Parrondo, Susan M. Schwager, Taimur Sher, Curtis A. Hanson, Min Shi, Daniel L. Van Dyke, Esteban Braggio, Susan L. Slager, Neil E. Kay, Sameer A. Parikh
Publikováno v:
Blood Cancer Journal, Vol 12, Iss 9, Pp 1-6 (2022)
Abstract Patients with chronic lymphocytic leukemia (CLL) with disease progression on ibrutinib have worse outcomes compared to patients stopping ibrutinib due to toxicity. A better understanding of expected outcomes in these patients is necessary to
Externí odkaz:
https://doaj.org/article/c5ee38417b3b4e7f8218d469cd1ba54f
Autor:
Aldo A. Acosta-Medina, Isla McKerrow Johnson, Radhika Bansal, Matthew Hathcock, Saad J. Kenderian, Urshila Durani, Arushi Khurana, Yucai Wang, Jonas Paludo, Jose C. Villasboas, N. Nora Bennani, Patrick B. Johnston, Stephen M. Ansell, Yi Lin, Hassan B. Alkhateeb
Publikováno v:
Blood Cancer Journal, Vol 13, Iss 1, Pp 1-3 (2023)
Externí odkaz:
https://doaj.org/article/7210ed18416a4266a7113384ed9b123a
Autor:
Sanjal H. Desai, Levi Pederson, Betsy LaPlant, Raphael Mwangi, Matthew Maurer, Jason R. Young, William R. Macon, Rebecca L. King, Yucai Wang, James R. Cerhan, Andrew Feldman, David J. Inwards, Ivana Micallef, Patrick Johnston, Luis F. Porrata, Stephen M. Ansell, Thomas M. Habermann, Thomas E. Witzig, Grzegorz S. Nowakowski
Publikováno v:
Blood Cancer Journal, Vol 12, Iss 5, Pp 1-6 (2022)
Abstract Studies evaluating Positron Emission Tomography scan after 2 cycles of chemotherapy (PET2) in newly diagnosed diffuse large B cell lymphoma (DLBCL) are heterogeneous in patient characteristics, treatments and have conflicting results. Here w
Externí odkaz:
https://doaj.org/article/78c8b113aa5c400095ef1c63894b6828
Autor:
Yucai Wang, Shouhao Zhou, Xinyue Qi, Fang Yang, Matthew J. Maurer, Thomas M. Habermann, Thomas E. Witzig, Michael L. Wang, Grzegorz S. Nowakowski
Publikováno v:
Blood Cancer Journal, Vol 12, Iss 1, Pp 1-9 (2022)
Abstract Front-line treatment for follicular lymphoma has evolved with the introduction of maintenance therapy, bendamustine (Benda), obinutuzumab (G), and lenalidomide (Len). We conducted a random-effects Bayesian network meta-analysis (NMA) of phas
Externí odkaz:
https://doaj.org/article/51f844b659894e18bc8376532b1a56f9
Autor:
Rebecca L. King, Alia Gupta, Paul J. Kurtin, Wei Ding, Timothy G. Call, Kari G. Rabe, Saad S. Kenderian, Jose F. Leis, Yucai Wang, Susan M. Schwager, Susan L. Slager, Neil. E. Kay, Amber Koehler, Stephen M. Ansell, David J. Inwards, Thomas M. Habermann, Min Shi, Curtis A. Hanson, Matthew T. Howard, Sameer A. Parikh
Publikováno v:
Blood Cancer Journal, Vol 12, Iss 1, Pp 1-7 (2022)
Abstract The distinction between chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL) with isolated Hodgkin/Reed–Sternberg cells (CLL-HRS; background milieu with a paucity of inflammatory cells) and overt transformation to classic Hodg
Externí odkaz:
https://doaj.org/article/989c3e3359c44e3abd2c16b6d6766da6
Autor:
Sanjal H. Desai, Betsy LaPlant, William R. Macon, Rebecca L. King, Yucai Wang, David J. Inwards, Ivana Micallef, Patrick B. Johnston, Luis F. Porrata, Stephen M. Ansell, Thomas M. Habermann, Thomas E. Witzig, Grzegorz S. Nowakowski
Publikováno v:
Blood Cancer Journal, Vol 11, Iss 9, Pp 1-7 (2021)
Abstract Diffuse large B-cell lymphoma (DLBCL), either concurrent with or transformed from follicular lymphoma (FL) is often excluded from clinical trials. Lenalidomide has response rates of 45% in relapsed transformed DLBCL. Herein we present an ana
Externí odkaz:
https://doaj.org/article/f4212dffb29c4151bf80a173ed91804d
Autor:
Yucai Wang, Sara J. Achenbach, Kari G. Rabe, Tait D. Shanafelt, Timothy G. Call, Wei Ding, Saad S. Kenderian, Eli Muchtar, Jose F. Leis, Amber B. Koehler, Susan M. Schwager, James R. Cerhan, Susan L. Slager, Neil E. Kay, Sameer A. Parikh
Publikováno v:
Blood Cancer Journal, Vol 11, Iss 8, Pp 1-4 (2021)
Externí odkaz:
https://doaj.org/article/863bb1613c0f4313b4f20f6c1c59d34d
Autor:
Kitsada Wudhikarn, Radhika Bansal, Arushi Khurana, Matthew A. Hathcock, N. Nora Bennani, Jonas Paludo, Jose C. Villasboas, Yucai Wang, Patrick B. Johnston, Stephen M. Ansell, Yi Lin
Publikováno v:
Blood Cancer Journal, Vol 11, Iss 7, Pp 1-5 (2021)
Externí odkaz:
https://doaj.org/article/3651d923700849a6874fb3f873c7a3e7